← Return to Insurance coverage for Actemra infusion with straight Medicare?
DiscussionInsurance coverage for Actemra infusion with straight Medicare?
Polymyalgia Rheumatica (PMR) | Last Active: 16 hours ago | Replies (25)Comment receiving replies
Replies to "I was diagnosed with PMR/GCA in July 2024. Started on 60 mg. of prednisone. In early..."
Thanks to you and to others who have answered. I now am fairly confident that Medicare will cover the Tyenne ( Actemra biosimilar) infusions. The order was put in and they called me to schedule but I held off because of my doubts. I'm going to wait until my next lab draw and MD visit in about a month. That way I'll have a good baseline on the labs since the Kevzara I recently got off had caused some abnormalities.
The problem is that Actemra is only FDA approved for GCA and not always authorized for treating PMR. Some doctors will assume there is underlying GCA or "presumptive GCA" for people who are diagnosed with PMR. Since there isn't any definitive way to diagnose either PMR or GCA it is mostly diagnosed based on symptoms and presenting characteristics.
A rapid response to prednisone tends to "confirm" the diagnosis of PMR/GCA but that is misleading at best. Most all inflammatory conditions will respond to Prednisone. Other than PMR/GCA, there aren't that many conditions still being treated with "long term" Prednisone because of the side effects of long term use. Until relatively recently, Prednisone was called the "only option" for PMR/GCA so people get left on Prednisone forever sometimes.
Kevzara is FDA approved for PMR but it only comes in an injectable form. I would think Kevzara will have an infusible formulation in the future. However, there needs to be more research submitted to the FDA for an infusible formulation of Kevzara to be FDA approved for PMR.